INSIGHTS ON DRUG DEVELOPMENT
-
Spray Drying With A Buchi-B290
Dr. Jordan Potts demonstrates how the Buchi B‑290 spray dryer works and explains its use in spray drying and particle engineering research.
-
Patented Process For Intermediates Useful For Etrasimod Arginine
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Nanomedicine Modalities Find Path To Clinic Through Analytics
Lipid nanoparticles have revolutionized drug delivery, ushering in a new era of nanomedicine. Discover how advanced analytical tools are accelerating next-generation LNP therapeutics.
-
Chromatography Polishing Under Pressure: New Demands9/11/2026
Upstream productivity gains and evolving antibody formats are raising the bar for chromatography polishing, making it a more consequential variable in downstream process design.
-
From 51% Yield To 87% With Targeted Impurity Removal5/7/2026
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
Managing Process Knowledge Throughout Drug Development And Manufacturing10/21/2025
Discover how digitalizing recipe and risk management helps life sciences teams accelerate drug development, streamline technology transfers, and simplify compliance to improve data integrity.
-
Accelerate Drug Development With Phase-Appropriate Thinking9/23/2026
Successful drug development requires more than a one-size-fits-all approach. Explore strategies tailored to each stage of the journey.
-
Five Practical Considerations To Move From Concept To Clinic12/17/2025
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
DRUG DEVELOPMENT SOLUTIONS
-
Access the future of AI microscopy
Subjectivity of analysis and poor reproducibility are key hurdles to be overcome for biological image analysis. Standard segmentation can lead to sub-standard results and require substantial manual curation which is subject to human error.
-
Peptides occupy a therapeutic niche between small molecules and large biologics. We understand the fundamental physiological challenges to peptide delivery and that there is no “one-size-fits-all” approach for formulation design.
-
Our comprehensive pharmaceutical development service offering includes new drug development, early stage formulation and analytical development for both highly potent and non-potent drug products.
-
Characterize Samples and Identify Unknown Components
Do you often need to identify unknown compounds from complex samples? ACD/MS Structure ID Suite offers a simple, replicable workflow for generating and narrowing down structural candidates.
- Deconvolute complex LC/MS and GC/MS data into individual component traces
- Search proprietary and commercial databases for spectral matches
- Search PubChem for accurate-mass and molecular-formula matches
- Narrow down candidate structures by retention time and fragment include/exclude lists
-
Hydrolysis probes built on minor groove binder chemistry pair shorter sequences with low background, offering gene-specific quantification across protein-coding genes without the assay development.